(1 - 39 von 83
)
Lilly and Incyte Announce Baricitinib Efficacy and Safety ...Eli Lilly and Company
investor.lilly.com
Contacts: Lilly: Media: Sonja Popp-Stahly , + , . Investors: Phil Johnson , + , johnson_philip_l ...
LILLY (ELI) & COMPANY - Phase 3 RA Program discontinued for Tabalumab
www.finanznachrichten.de
Date: February 7, For Release: Immediately Refer to: Media: Sonja Popp-Stahly, + , ; Investors:
Sonja Popp-Stahly Hi-Res Aug PRSA Hoosier
www.prsahoosier.org
Sonja Popp-Stahly Hi-Res Aug PRSA Hoosier > Events > PRSA Hoosier Chapter Luncheon — What to do before and after a ...
LILLY (ELI) & COMPANY - Tabalumab RA Study BCDM Discontinuation
www.finanznachrichten.de
Date: December 13, For Release: Immediately Refer to: Media: Sonja Popp-Stahly, + , ;
Investors: Phil
sortiert nach Relevanz / Datum